Oncology Central

Study challenges century-old understanding of cancer metabolism

Researchers at the Children’s Medical Center Research Institute (CRI) of UT Southwestern (TX, USA) have observed that growing cancer cells are able to use lactate as a fuel source, thus contradicting previous knowledge of cancer-cell metabolism.

The Warburg effect, proposed by Otto Warburg famously suggests that in growing tumors; there is rapid glucose uptake, reduced glucose oxidation even in oxygen, and finally secretion of lactate as a waste product.

In a previous study (published in Cell), the CRI researchers challenged the second component of the Warburg effect as they reported high glucose oxidation in human non-small-cell lung cancer cells (NSCLCs) via the tricarboxylic acid (TCA) cycle.

In the current study also published in Cell, the CRI researchers observed how NSCLCs metabolized glucose and lactate in vivo. The researchers demonstrated that in addition to glucose, NSCLCs utilized lactate as a carbon source for oxidation. In fact, when the researchers directly compared lactate and glucose metabolism in vivo, they discovered that lactate’s contribution to the TCA cycle was greater. This finding as well as the finding from the previous study challenges the fundamental understanding of cancer metabolism proposed by Warburg.

Want to find out more about the Warburg effect? Read the Future Oncology article below:

Potential targets of energy restriction mimetic agents in cancer cells

Ralph DeBerardinis, the lead researcher of this study commented; “Our finding is a fundamental change in how we think about tumor metabolism”. He went on to say: “We believe that lactate is one of the fuels that supports growth, proliferation, and maybe even lung cancer metastases.
The latter part of DeBerardinis’ statement is supported by evidence found in this study of a potential link between lactate metabolism and aggression of the tumors.

Despite the findings from this study, the extent of lactate’s contribution to energy metabolism in living cancer cells is still unknown. However, the researchers hope that this study may shift the focus of future research to understanding the lactate pathway. As DeBerardinis proclaims: “…understanding the lactate pathway could help us find therapeutic targets for lung cancer. Lactate uptake could also have predictive value when used as an imaging tracer.”

Faubert B, Li KY, Cai L et al. Lactate metabolism in human lung tumors. Cell 171(2), 358–371.e9 (2017); UTSouthwestern press release 




News Headlines

1 Comment

  1. Follows another study, published this month, that advocates the same direction:
    Carlos ETB Monteiro, “Stress as the Inductive Factor for Increased Lactate Production: The Evolutionary Path to Carcinogenesis”. Positive Health Online, Edition 241, October, 2017 at http://www.positivehealth.com/article/cancer/stress-inductive-factor-for-increased-lactate-production-evolutionary-path-to-carcinogenesis
    In the present paper is discussed about the recent evolution in the understanding of the role of lactate formation in promoting cancer.
    On it is postulated the hypothesis that chronic stress is the major risk factor and inductor of the increased lactate production which might lead to the carcinogenic process. It also explains how stress develops lactate formation, what was discovered in 1925.
    The current hypothesis support ketogenic diets for prevention and therapy for cancer. This inside the reasoning that while fats do not have appreciable effects on the sympathetic nervous system (SNS) or in lactate formation, high carbohydrate diets have significantly effects on both SNS and lactate formation.
    At the end of the paper has a short explanation and link to a parallel article where is discussed cardiac glycosides (ex.: digitalis like digoxin) as the fundamental drugs for prevention and treatment of cancer.

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.